Kerry will work with governments, development partners, multilateral institutions, civil society and the private sector to advocate for stronger health systems and more sustainable health financing.
The appointment of Rabier is intended to help Sanner maximize these expanded capabilities by developing new markets, strengthening relationships with customers, and supporting the company’s international growth strategy.
Dr Tapela holds a Doctor of Medicine (MD) degree and a Master of Public Health (MPH) degree from Harvard University.
The appointments will see Dr. Patel take over the chairmanship from Dr. Manoj Shah, who has led the Board through a period of significant development for the Nairobi-based hospital.
Kalyan brings nearly 30 years of experience in the pharmaceutical and healthcare industries, including 18 years with Novo Nordisk.
The appointment comes as Africa intensifies efforts to strengthen its response to the ongoing Ebola outbreak while accelerating the development of African-led medicines, vaccines and outbreak-ready innovations.
The new CFO succeeds Henrik Bøggild, who left the company after three and a half years to pursue another professional opportunity.
Dr. Melly currently serves as Kenya’s cancer country counterpart lead for the International Atomic Energy Agency and is affiliated with several global oncology bodies, including the Union for International Cancer Control and the Association of American Cancer Institutes.
Ambassador Ratebaye brings decades of experience in diplomacy, public international law, governance, and multilateral negotiation.
The inaugural eight-member ASAG brings together experts in pathogen genomics, human genomics, bioinformatics, clinical genetics, precision medicine, ethics, and public health.